Ethyl 4,6-Dichloroquinazoline-2-Carboxylate: Properties & Uses
Ethyl 4,6-Dichloroquinazoline-2-Carboxylate: Properties & Uses
Ethyl 4,6-dichloroquinazoline-2-carboxylate is a bifunctional quinazoline derivative bearing two electrophilic chloro substituents and an ester handle, making it a highly versatile intermediate for the construction of pharmacologically relevant heterocyclic compounds.
- Chemical Name
- Ethyl 4,6-dichloroquinazoline-2-carboxylate
- SKU
- E729424
- Core Scaffold
- Quinazoline (bicyclic benzene-pyrimidine heterocycle)
- Reactive Sites
- C-4 and C-6 chloro groups; C-2 ethyl ester
- Primary Application
- Intermediate in medicinal chemistry and kinase inhibitor synthesis
- Supplier
- Aladdin Scientific
Chemical Identity and Structure
Ethyl 4,6-dichloroquinazoline-2-carboxylate is a member of the quinazoline family, a class of bicyclic heteroaromatic compounds consisting of a benzene ring fused to a pyrimidine ring. The compound carries chlorine substituents at the 4- and 6-positions of the quinazoline ring system, and an ethyl ester (–CO2Et) group at the 2-position. This combination of functional groups endows the molecule with multiple distinct sites for chemical elaboration: the C-4 chloro group is particularly activated toward nucleophilic aromatic substitution (SNAr) due to the electron-withdrawing effect of the ring nitrogen atoms, while the C-6 chloro group offers an additional handle for further functionalization or cross-coupling reactions. The ethyl ester at C-2 can be hydrolyzed, reduced, or converted to amides and other derivatives, broadening the synthetic scope of this building block considerably.
Synthetic Applications and Reactivity
The dual chloro substitution pattern of Ethyl 4,6-dichloroquinazoline-2-carboxylate enables sequential and selective functionalization strategies widely employed in drug discovery programs. The C-4 position is typically more electrophilic than C-6, allowing chemists to achieve regioselective displacement with amines, alcohols, or thiol nucleophiles under mild conditions to install the first diversity element. Subsequent modification at C-6 can then be accomplished via palladium-catalyzed cross-coupling reactions (e.g., Suzuki–Miyaura, Buchwald–Hartwig) or a second SNAr step, providing rapid access to highly substituted quinazoline libraries.
The C-2 ester group further expands utility: saponification yields the corresponding carboxylic acid for amide coupling; reduction with DIBAL-H or LiBH4 affords the aldehyde or alcohol; and treatment with hydrazine or hydroxylamine generates useful nitrogen-containing heterocyclic derivatives. This multi-point diversifiability makes the compound an attractive scaffold for parallel synthesis and high-throughput screening campaigns.
Applications in Medicinal Chemistry and Drug Discovery
Quinazoline derivatives occupy a privileged position in medicinal chemistry, with numerous approved drugs built on this bicyclic scaffold, particularly in oncology. Compounds such as gefitinib, erlotinib, and lapatinib—all EGFR kinase inhibitors—highlight the therapeutic relevance of 4-aminoquinazolines. Ethyl 4,6-dichloroquinazoline-2-carboxylate serves as a direct precursor to analogous scaffolds, enabling researchers to rapidly generate focused libraries targeting receptor tyrosine kinases, cyclin-dependent kinases, and other therapeutically validated targets.
Beyond kinase inhibitors, the quinazoline-2-carboxylate motif has been explored in antimicrobial, anti-inflammatory, and antiparasitic research contexts. The ester at C-2 provides a handle for introducing pharmacophoric groups that modulate solubility, membrane permeability, and binding affinity—key parameters in lead optimization. Researchers in fragment-based drug design may also employ this compound as a fragment or as a fragment-elaboration starting point given its molecular weight and synthetic tractability.
Handling, Storage, and Safety Considerations
As with most reactive halogenated heterocyclic intermediates, Ethyl 4,6-dichloroquinazoline-2-carboxylate should be handled with appropriate precautions. Standard laboratory personal protective equipment—including nitrile gloves, safety goggles, and a lab coat—is recommended. Work should be conducted in a well-ventilated fume hood to minimize inhalation exposure to the solid or any vapors generated during reactions.
The compound should be stored under dry conditions, away from moisture, heat, and light, typically at room temperature or below (2–8 °C is often recommended for long-term stability of reactive chloroquinazolines). Containers should be tightly sealed when not in use to prevent hydrolysis of the C-4 chloro group or the ester functionality. Disposal must comply with local regulations for halogenated organic waste. Researchers are advised to consult the Safety Data Sheet (SDS) provided by Aladdin Scientific for comprehensive hazard, first-aid, and disposal information specific to this product.
Frequently asked questions
What makes the C-4 chloro group of Ethyl 4,6-dichloroquinazoline-2-carboxylate more reactive than the C-6 chloro group?
The C-4 position is flanked by both ring nitrogen atoms of the quinazoline system, which significantly increase the electrophilicity of that carbon through inductive and resonance withdrawal of electron density. This makes C-4 substantially more susceptible to nucleophilic aromatic substitution (SNAr) compared to C-6, enabling regioselective functionalization under mild conditions.
Can the ethyl ester at the 2-position be converted to other functional groups?
Yes. The C-2 ethyl ester is amenable to standard ester transformations: base hydrolysis yields the carboxylic acid, which can then undergo amide coupling; reduction with hydride reagents can afford the corresponding aldehyde or primary alcohol; and condensation with hydrazine or hydroxylamine produces hydrazide or hydroxamic acid derivatives, respectively. These transformations greatly expand the diversity of compounds accessible from this single building block.
How should Ethyl 4,6-dichloroquinazoline-2-carboxylate be stored to maintain its stability?
The compound should be stored in a tightly sealed container under dry, cool conditions, away from moisture, heat, and light. Refrigerated storage (2–8 °C) is generally recommended for long-term stability of reactive chloroquinazolines to prevent hydrolysis of the labile C-4 chloro group and the ester functionality. Always consult the product SDS for specific storage recommendations.
Is Ethyl 4,6-dichloroquinazoline-2-carboxylate suitable for Suzuki–Miyaura cross-coupling reactions?
Yes, the C-6 aryl chloride can participate in palladium-catalyzed Suzuki–Miyaura cross-coupling reactions with arylboronic acids or esters under appropriate reaction conditions (Pd catalyst, base, suitable solvent). Selective coupling at C-6 after prior Sᵎar modification at C-4 allows the construction of bi-aryl and heteroaryl-substituted quinazoline scaffolds of interest in drug discovery.
References
- Carey, F. A.; Sundberg, R. J. Advanced Organic Chemistry, Part B: Reactions and Synthesis, 5th ed.; Springer: New York, 2007. (General principles of SNAr and ester reactivity)
- Arrowsmith, J. E. et al. Quinazoline-based kinase inhibitors in medicinal chemistry: a review. (General review — specific citation details require verification.)
- Miyaura, N.; Suzuki, A. Palladium-Catalyzed Cross-Coupling Reactions of Organoboron Compounds. Chem. Rev. 1995, 95, 2457–2483. doi:10.1021/cr00039a007
Products are supplied for research and development use only. Not for use in humans, animals, diagnosis, or therapy.
危险品化学品经营许可证(带存储)